Oncology & Cancer

Portrazza approved for advanced lung cancer

(HealthDay)—Portrazza (necitumumab), in combination with two other chemotherapy drugs, has been approved by the U.S. Food and Drug Administration to treat advanced squamous non-small cell lung cancer, the agency said Tuesday ...

Medications

FDA approves drug to reverse blood thinner Pradaxa

Federal health regulators have approved a drug to reverse the blood-thinning effects of the popular pill Pradaxa, which has been subject to thousands of reports of severe bleeding.

Cardiology

Predicting arrhythmias so as to prevent them

Researchers have discovered how to predict some cardiac arrhythmias several steps before they even occur. It's a finding that could lead to an improved cardiac device, with equipment designed to detect when arrhythmias are ...

page 15 from 30